Join us for a structured, 4-Zoom Live Session Course, designed to equip you with the most current, evidence-based approaches to benzodiazepine tapering—based on the newly released 2025 ASAM Clinical Practice Guideline.
- May 17 (Saturday): 10 am to 12 pm.
Whether you're supporting patients with long-term benzodiazepine use, navigating challenging withdrawal symptoms, or balancing risk-benefit decisions, this course will provide the tools and clarity you need.
Introducing the 2025 ASAM Guideline:
The 2025 guideline equips practitioners with the latest evidence to navigate the benzodiazepine tapering decisions. Its recommendations balance harm reduction with patient needs.
Evidence-Informed Approach:
Comprehensive, consensus-based strategies for clinicians making tapering decisions.
Patient-Centered Focus:
Structured approaches for safely reducing and discontinuing benzodiazepines.
Specific Application for:
Designed for adult patients using benzodiazepines regularly who risk physical dependence.
Master the Latest Tapering Guidelines with Confidence:
4 Live Zoom Sessions
Four live Zoom sessions conducted by Dr. Harvinder Singh, who will distill the essential clinical details from the comprehensive 200+ page guideline.
Structured Learning
Join our structured program designed to equip you with the most current, evidence-based approaches to benzodiazepine tapering based on the 2025 ASAM Guidelines.
Practical Application
Gain practical tools to support patients with long-term BZD use, navigate withdrawal symptoms, and make informed risk-benefit decisions.
🧭 Course Outline: What You'll Learn
[Live Session 1]: May 17, 10 am PST
📘Foundational Principles & Decision-Making
- ✅ Understand all 28 recommendations from the 2025 ASAM Guideline
- ✅ Develop a risk–benefit decision framework: Should you taper?
- ✅ Clarify the distinction between tapering vs discontinuation
- ✅ Engage in shared decision-making through patient-centered discussions
- ✅ Determine appropriate level of care: Outpatient vs Inpatient
[Live Session 2]: May 17, 10:30 am PST
⚖️ Designing & Monitoring the Taper
- ✅ Learn how to initiate and structure the tapering process
- ✅ Explore individualized tapering scenarios—it's not one-size-fits-all
- ✅ Understand recommended monitoring strategies during the taper
- ✅ Principles of transitioning to longer-acting benzodiazepines
- ✅ Management of mild, moderate, and severe withdrawal symptoms
- ✅ Assess and manage seizure risk during benzodiazepine taper
- ✅ Guidance on tapering as you approach discontinuation
[Live Session 3]: May 17, 11 am PST
🧪 Adjunctive Strategies & Complication Management
- ✅ Evidence-based adjunctive interventions to support tapering
- ✅ Role of behavioral interventions in the taper process
- ✅ Importance of sleep hygiene in withdrawal management
- ✅ Pharmacological agents for supporting benzodiazepine tapering
- ✅ Managing severe or complicated withdrawal symptoms
- ✅ Clinical considerations: Is Phenobarbital tapering recommended?
- ✅ Medications to avoid during benzodiazepine tapering
- ✅ Understand and manage protracted withdrawal syndromes
[Live Session 4]: May 17, 11:30 am PST
🧬 Special Populations & Complex Clinical Scenarios
- ✅ Tapering in patients co-prescribed opioids
- ✅ Strategies for patients with benzodiazepine & other substance use disorders
- ✅ Managing patients with co-occurring psychiatric disorders
- ✅ Identify psychiatric conditions where tapering is strongly warranted
- ✅ Special considerations for older adults: clinical decision-making and risks
- ✅ Recommendations for pregnant or lactating patients
- ✅ Revisit key principles for starting and adapting the tapering plan
Meet Your Instructor:
Dr. Harvinder Singh, MD
Clinical Expertise
- Board-certified psychiatrist
Teaching Excellence
- Creator of Psychiatry Education Forum
🎯 Who Should Attend?
Psychiatrists & Psychiatry Residents
Primary Care Physicians
Nurse Practitioners
Physician Assistants
If you care for patients using benzodiazepines, this course is for you.
💳 Pricing
Academy Members
FREE with your active membership—access this course plus 470+ clinical lessons and our complete CME library.
Non-Members
One-time payment for permanent access to this high-impact course. No subscription required.
Register Now and Stay Clinically Updated
Lifetime Access
Enrolled students receive permanent access to all course recordings and presentation materials.
Register today to transform your approach to benzodiazepine management.
Evidence-Based Benzodiazepine Tapering: 2025 ASAM Guideline in Practice